Types, Dimensions and Aetiology



The heterogeneity of alcohol-dependent patients is nowadays undoubted. In the last 100 years, subgroups have been defined using mainly cross-sectional data, collected during treatment. Organizing an investigation in a catchment area, it was necessary to build up a team with a therapeutic and scientific approach. Together with this team, we could organize the start of a prospective long-term study. Defining four different long-term courses, we were able to develop a decision tree of symptoms. This decision tree is the basis of the computerized version ( For more than 20 years, this computer programme is available in 17 languages and free of charge. It is used in many countries for studies on genetics, biology and therapy approaches.


  1. Addolorato G, Capristo E, Leggio L, Ferrulli A, Abenavoli L, Malandrino N, Farnetti S, Domenicali M, D’Angelo C, Vonghia L, Mirijello A, Cardone S, Gasbarrini G. Relationship between ghrelin levels, alcohol craving and nutritional status in current alcoholics. Alcohol Clin Exp Res. 2006;30:1933–7.PubMedCrossRefGoogle Scholar
  2. Angst J. The course of monopolar depression and bipolar psychosis. Psychiatr Neurol Neurochir. 1973;76(6):489.PubMedGoogle Scholar
  3. Angst J, Gamma A, Endrass J, Rössler W, Ajdacic-Gross V, Eich D, Herrell R, Merikangas KR. Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar – II disorder? Eur Arch Psychiatry Clin Neurosci. 2006;256:452–7.PubMedCrossRefPubMedCentralGoogle Scholar
  4. Anton RF, Moak DH, Latham P. The obsessive compulsive drinking scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behaviour. Alcohol Clin Exp Res. 1995;19:92–9.PubMedCrossRefGoogle Scholar
  5. Attilia F, Perciballi R, Rotondo C, Capriglione I, Iannuzzi S, Attilia ML, Vitali M, Alessandrini G, Scamporrino MCM, Fiore M, Ceccanti M. Pharmacological treatment of alcohol use disorder. Scientific evidence. Riv Psichiatr. 2018;53(3):123–7.PubMedGoogle Scholar
  6. Babor T, De Hoffman MI, Boca F, Hesselbrock V, Meyer R, Dolinsky Z, Rounsaville B. Types of alcoholics. I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry. 1992;49:599–608.PubMedCrossRefGoogle Scholar
  7. Bananej A, Völkl-Kernstock S, Lesch O, Walter H, Skala K. No evidence of subgroups found in amphetamine consumers in Iran. Neuropsychiatrie. 2018;32(2):69–74.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Basu D, Ball SA, Feinn R, Gelernter J, Kranzler HR. Typologies of drug dependence: comparative validity of a multivariate and four univariate models. Drug Alcohol Depend. 2004;73:289–300.PubMedCrossRefGoogle Scholar
  9. Benyamina A, Saffroy R, Blecha L, Pham P, Karila L, Debuire B, Lemoine A, Reynaud M. Asociation between MTHFR 677C-T polymorphism and alcohol dependence according to Lesch and Babor typology. Addict Biol. 2009;14(4):503–5.PubMedCrossRefGoogle Scholar
  10. Berner P. Psychiatrische Systematik Huber. Wien: Bern Stuttgart; 1986.Google Scholar
  11. Berrettini WH, Lerman CE. Pharmacotherapy and pharmacogenetics of nicotine dependence. Am J Psychiatry. 2005;162(8):1441–51. ReviewPubMedCrossRefGoogle Scholar
  12. Biermann T, Reulbach U, Lenz B, Muschler M, Sperling W, Hillemacher T, Kornhuber J, Bleich S. Herp mRNA expression in patients classified according to Lesch's typology. Alcohol. 2009;43(2):91–5.PubMedCrossRefGoogle Scholar
  13. Bleich S, Bayerlein K, Reulbach U, Hillemacher T, Bonsch D, Mugele B, Kornhuber J, Sperling W. Homocysteine levels in patients classified according to Lesch’s typology. Alcohol Alcohol. 2004;39(6):493–8.PubMedCrossRefPubMedCentralGoogle Scholar
  14. Bleuler M. Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken- und Familiengeschichten. Stuttgart: Thieme; 1972.Google Scholar
  15. Bleuler M. Lehrbuch der Psychiatrie. 15th ed: Springer Verlag; 1983.Google Scholar
  16. Bogenschutz MP, Scott TJ, Pettinati HM. Effects of alcoholism typology on response to naltrexone in the COMBINE study. Alcohol Clin Exp Res. 2009;33(1):10–8.PubMedCrossRefGoogle Scholar
  17. Bönsch D, Bayerlein K, Reulbach U, Fiszer R, Hillemacher T, Sperling W, Kornhuber J, Bleich S. Different allele-distribution of MTHFR 677 C -> T and MTHFR -393 C -> a in patients classified according to subtypes of Lesch’s typology. Alcohol Alcohol. 2006;41(4):364–7.PubMedCrossRefPubMedCentralGoogle Scholar
  18. Borland R, Murray K, Gravely S, Fong GT, Thompson ME, McNeill A, O'Connor RJ, Goniewicz ML, Yong HH, Levy DT, Heckman BW, Cummings KM. A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called 'dual use'): findings from the ITC-4 country smoking and Vaping wave 1 survey. Addiction. 2019;114(1):24–34.Google Scholar
  19. Brown J, Babor TF, Litt M, Kranzler H. The type a/type B distinction. Subtyping alcoholics according to indicators of vulnerability and severity. Babor T, Hesselbrock V, Meyer R, Shoemaker W. Types of Alcoholics. Ann N Y Acad Sci. 1994;708:23–33.PubMedCrossRefGoogle Scholar
  20. Caputo F, Del Re A, Brambilla R, Grignaschi A, Vignoli T, Vigna-Taglianti F, Addolorato G, Zoli G, Cibin M, Bernardi M. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: a pilot study. J Psychopharmacol. 2014;28(1):23–30.PubMedCrossRefPubMedCentralGoogle Scholar
  21. Cardoso Neves JM, Barbarosa A, Ismail F, Pombo S. NETER alcoholic typology (NAT). Alcohol Alcohol. 2006;41(2):133–9.CrossRefGoogle Scholar
  22. Coppola M, Mondola R. Correlation between plasma homocysteine levels and craving in alcohol dependent stabilized patients. Clin Nutr. 2018;37:1061–5.PubMedCrossRefGoogle Scholar
  23. Del Boca FK. Sex, gender and alcoholic typologies. Babor T, Hesselbrock V, Meyer R, Shoemaker W. Types of Alcoholics. Ann N Y Acad Sci. 1994;708:34–48.PubMedCrossRefGoogle Scholar
  24. Del Boca FK, Hesselbrock MN. Gender and alcoholic subtypes. Alcohol Health Res World. 1996;20:56–66.PubMedPubMedCentralGoogle Scholar
  25. Diaz FJ, Jane M, Salto E, Pardell H, Salleras L, Pinet C, De Leon J. A brief measure of high nicotine dependance for busy clinicians and large epidemiological surveys. Aust N Z J Psychiatry. 2005;39:161–8.PubMedCrossRefGoogle Scholar
  26. Driessen M, Meier S, Hill A, Wetterling T, Lange W, Junghanns K. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol. 2001;36(3):249–55.PubMedCrossRefGoogle Scholar
  27. Eysenck HJ. Personality and the maintenance of the smoking habit. Dunn WL. Smoking behavior: motives and incentives. Toronto Wiley. 1973: 113–136.Google Scholar
  28. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström tolerance questionnaire. J Behav Med. 1989;12(2):159–82.PubMedCrossRefGoogle Scholar
  29. Foroud T, Bucholz KK, Edenberg HJ, Goate A, Neuman RJ, Porjesz B, Koller DL, Rice J, Reich T, Bierut LJ, Cloninger CR, Nurnberger JI, Li TK Jr, Conneally PM, Tischfield JA, Crowe R, Hesselbrock V, Schuckit M, Begleiter H. Evidence for linkage of an alcohol-related phenotype to chromosome 16. Alcohol Clin Exp Res. 1998;22:2035–42.PubMedCrossRefGoogle Scholar
  30. Foucault M. Power/knowledge: selected interviews and other writings 1972–77. New York: Pantheon; 1980.Google Scholar
  31. Gilligan SB, Reich T, Cloninger CR. Etiologic heterogeneity in alcoholism. Genet Epidemiol. 1987;4:395–414.PubMedCrossRefPubMedCentralGoogle Scholar
  32. Grünberger J. Humaner Strafvollzug. Am Beispiel Sonderanstalt Mittersteig. Wien, New York: Springer; 2007.Google Scholar
  33. Grünberger J, Lesch OM, Linzmayer L. Bestimmung von vier Alkoholikertypen mit Hilfe der statischen und licht-evozierten dynamischen Pupillometrie. Wiener Zeitschrift für Suchtforschung. 1988;11(4):29–34.Google Scholar
  34. Grzywacz A, Małecka I, Korostyński M, Przewłocki R, Bieńkowski P, Samochowiec J. GABA-A receptor genes do not play a role in genetics of Lesch's typology in Caucasian subjects. Arch Med Sci. 2012;8(2):357–61.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Gsellhofer B, Fahrner EM, Weiler D, Vogt M, Hron U. Deutsche Version: (IFT Institut für Therapieforschung) und J. Platt (Hahnemann University); nach dem amerikanischen Original von T. McLellan, 5. Ed., 1992, und der europäischen Version Europ ASI von A. Kokkevi, Ch. Hartgers, P. Blanken, E.-M. Fahrner, G. Pozzi, E. Tempesta& A. Uchtenhagen; 1993.Google Scholar
  36. Hanak C, Benoit J, Fabry L, Hein M, Verbanck P, de Witte P, Walter H, Dexter DT, Ward RJ. Changes in pro-inflammatory markers in detoxifying chronic alcohol abusers, divided by LeschTypology, reflect cognitive dysfunction. Alcohol Alcohol. 2017;52(5):529–34.PubMedCrossRefPubMedCentralGoogle Scholar
  37. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86:1119–27.PubMedCrossRefPubMedCentralGoogle Scholar
  38. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84:791–9.PubMedCrossRefPubMedCentralGoogle Scholar
  39. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005a;55:281–99.PubMedCrossRefGoogle Scholar
  40. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy of nicotine dependence. CA Cancer J Clin. 2005b;55:281–91.PubMedCrossRefGoogle Scholar
  41. Hertling I, Ramskogler K, Dvorak A, Klingler A, Saletu-Zyhlarz G, Schoberberger R, Walter H, Kunze M, Lesch OM. Craving and other characteristics of the comorbidity of alcohol and nicotine dependence. Eur Psychiatry. 2005;20:442–50.PubMedCrossRefGoogle Scholar
  42. Hertling I, Walter H, Fischer DE, Lindner H, Ramskogler K, Lesch OM. Behnadlung der chronischen Alkoholabhängigkeit. Gibt es Untergruppen für Psychotherapie mit Hypnose. Hypnose und Kognition. Band. 2002;19:107–16.Google Scholar
  43. Hesselbrock MN, Hesselbrock V, Del Boca F. Typology of alcoholism, gender and 20-year mortality. Alcohol Clin Exp Res. 2001;25:151A.Google Scholar
  44. Hesselbrock VM, Hesselbrock MN. Are there empirically supported and clinically useful subtypes of alcohol dependence? Addiction. 2006;101(1):97–103.PubMedCrossRefGoogle Scholar
  45. Hillemacher T, Bayerlein K, Wilhelm J, Bönsch D, Poleo D, Sperling W, Kornhuber J, Bleich S. Recurrent detoxifications are associated with craving in patients classified as type 1 according to Lesch's typology. Alcohol Alcohol. 2006a;41(1):66–9.PubMedCrossRefPubMedCentralGoogle Scholar
  46. Hillemacher T, Bayerlein K, Wilhelm J, Frieling H, Sperling W, Kornhuber J, Bleich S. Prolactin serum levels and alcohol craving – an analysis using Lesch’s typology. Neuropsychobiology. 2006b;53:133–6.PubMedCrossRefPubMedCentralGoogle Scholar
  47. Hillemacher T, Bleich S. Neurobiology and treatment in alcoholism – recent findings regarding Lesch’s typology of alcohol dependence. Alcohol Alcohol. 2008;43(3):341–6.PubMedCrossRefPubMedCentralGoogle Scholar
  48. Hillemacher T, Bleich S, Frieling H, Schanze A, Wilhelm J, Sperling W, Kornhuber J, Kraus T. Evidence of an association of leptin serum levels and craving in alcohol dependence. Psychoneuroendocrinology. 2007a;32(1):87–90.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Hillemacher T, Kraus T, Rauh J, Wei J, Schanze A, Frieling H, Wilhelm J, Heberlein A, Gröschl M, Sperling W, Kornhuber J, Bleich S. Role of appetite-regulating peptides in alcohol craving: an analysis in respect to subtypes and different consumption patterns in alcoholism. Alcohol Clin Exp Res. 2007b;31(6):950–4.PubMedCrossRefPubMedCentralGoogle Scholar
  50. Hultberg B, Berglund M, Andersson A, Fran K. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res. 1993;17:687–9.PubMedCrossRefPubMedCentralGoogle Scholar
  51. Jabłonski M. Genetic determinants of the alcohol dependence syndrome: searching for an endophenotype associated with sweet liking in families with alcohol addiction. Ann Acad Med Stetin. 2011;57(1):79–87.PubMedGoogle Scholar
  52. Jakovljevic M, Jovanovic M, Rancic N, Vyssoki B, Djordjevic N. LAT software induced savings on medical costs of alcohol addicts' care--results from a matched-pairs case-control study. PLoS One. 2014;9(11):e111931.PubMedPubMedCentralCrossRefGoogle Scholar
  53. Jakovljevic M, Riegler A, Jovanovic M, Djordjevic N, Patek K, Lesch O, Walter H. Serbian and Austrian alcohol-dependent patients: a comparison of two samples regarding therapeutically relevant clinical features. Alcohol Alcohol. 2013;48(4):505–8.PubMedCrossRefGoogle Scholar
  54. Jellinek EM. The disease concept of alcoholism. New Brunswick, RI: Hillhouse; 1960.CrossRefGoogle Scholar
  55. Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry. 2004;61(9):905–12.PubMedCrossRefPubMedCentralGoogle Scholar
  56. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. J Am Med Assoc. 2000;284:963–71.CrossRefGoogle Scholar
  57. Kadden RM, Litt MD, Cooney NL, Kabela E, Getter H. Prospective matching of alcoholic clients to cognitive-behavioral or interactional group therapy. J Stud Alcohol. 2001;62:359–64.PubMedCrossRefGoogle Scholar
  58. Kamat PK, Mallonee CJ, George AK, Tyagi SC, Tyagi N. Homocysteine, alcoholism, and its potential epigenetic mechanism. Alcohol Clin Exp Res. 2016;40:2474–81.PubMedPubMedCentralCrossRefGoogle Scholar
  59. Kapusta ND, Ramskogler K, Hertling I, Schmid R, Dvorak A, Walter H, Lesch OM. Epidemiology of substance use in a representative sample of 18-year-old males. Alcohol Alcohol. 2006;41:188–92.PubMedCrossRefGoogle Scholar
  60. Kiefer F, Barocka A. Secondary depression in weaned alcoholics: implications of Lesch's typology of chronic alcoholism. Alcohol Alcohol. 1999;34(6):916–7.PubMedCrossRefGoogle Scholar
  61. Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, Wiedemann K. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res. 2005a;11:83–91.PubMedCrossRefPubMedCentralGoogle Scholar
  62. Kiefer F, Jahn H, Jaschinski M, Holzbach R, Wolf K, Naber D, Wiedemann K. Leptin: a modulator of alcohol craving? Biol Psychiatry. 2001a;49:782–87.Google Scholar
  63. Kiefer F, Jahn H, Wiedemann K. Aneuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment. Pharmacopsychiatry. 2005b;38(4):184–6.PubMedCrossRefPubMedCentralGoogle Scholar
  64. Kiefer F, Jahn H, Wolf K, Kampf P, Knaudt K, Wiedemann K. Free-choice alcohol consumption in mice after application of the appetite regulating peptide leptin. Alcohol Clin Exp Res. 2001b;25:787–89.Google Scholar
  65. Kiefer F, Jiménez-Arriero MA, Klein O, Diehl A, Rubio G. Cloninger’s typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Addict Biol. 2007;13:124–9.Google Scholar
  66. Kim DJ, Yoon SJ, Choi B, Kim TS, Woo YS, Kim W, Myrick H, Peterson BS, Choi YB, Kim YK, Jeong J. Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol Alcohol. 2005;40(1):76–9.PubMedCrossRefGoogle Scholar
  67. Knorring AL, Bohman MV, Knorring LV, Oreland L. Platelet MAO activity as biological marker in subgroups of alcoholism. Acta Psychiatr Scand. 1985;72:511–58.Google Scholar
  68. Kranzler HR, Burleson JA, Brown J, Babor TF. Fluoxetine treatment seems to reduce the beneficial effects of cognitive behavioral therapy in type B alcoholics. Alcohol Clin Exp Res. 1996;20:1534–41.PubMedCrossRefPubMedCentralGoogle Scholar
  69. Kraus T, Schanze A, Groschl M, Bayerlein K, Hillemacher T, Reulbach U, Kornhuber J, Bleich S. Ghrelin levels are increased in alcoholism. Alcohol Clin Exp Res. 2005;29(12):2154–7.PubMedCrossRefGoogle Scholar
  70. Le Foll B, Melihan-Cheinin P, Rostoker G, Lagrue G, Working Group of AFSSAPS. Smoking cessation guidelines: evidence-based recommendations of the French health products safety agency. Eur Psychiatry. 2005;20(5–6):431–41.PubMedCrossRefGoogle Scholar
  71. Lee SH, Lee BH, Lee JS, Chai YG, Choi MR, Han DM, Ji H, Jang GH, Shin HE, Choi IG. The association of DRD2-141C and ANKK1 TaqIA polymorphisms with alcohol dependence in Korean population classified by the Lesch typology. Alcohol Alcohol. 2013;48(4):426–32.PubMedCrossRefGoogle Scholar
  72. Leggio L, Kenna GA, Fenton M, Bonenfant E, Swift RM. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev. 2009;19(1):115–29.PubMedCrossRefGoogle Scholar
  73. Leitner A, Gierth L, Lentner S, Platz WE, Rommelspacher H, Schmidt L, Lesch OM. Untergruppen Alkoholkranker. Gibt es biologische Marker? Harman und Norharmanbefunde. In: Baumann P. (ed) Biologische Psychiatrie der Gegenwart. Springer Verlag, Wien, New York. 1994. p. 636–40.Google Scholar
  74. Lesch OM. Chronischer Alkoholismus – Typen und ihr Verlauf – eine Langzeitstudie. Thieme Copythek, Georg Thieme Verlag Stuttgart New York, 235 Seiten, 116 Tabellen; 1985.Google Scholar
  75. Lesch OM. Raucherentwöhnung – Tipps zur Prävention und Therapie in der Praxis: Uni-Med Verlag; 2007.Google Scholar
  76. Lesch OM, Benda N, Gutierrez K, König B, Ramskogler K, Riegler A, Semler B, Zyhlarz G, Walter H, Mader R. Addictive Behaviors on bipolar patients, classificatory issues. Psiquiatria Na Prática Médica. 1997a;10(6):14–21.Google Scholar
  77. Lesch OM, Benda N, Gutierrez K, Walter H. Craving in alcohol dependence-pharmaceutical interventions. In: Judd LL, Saletu B, Filip V, editors. Basic and clinical science of mental and addictive disorders. Bibliotheca Psychiatrica; 1997b. 167/12: p. 136–147.CrossRefGoogle Scholar
  78. Lesch OM, Bonte W, Grünberger J. Eine Typologie des chronischen Alkoholismus – Neue Basisdaten für Forschung und Therapie. In: Ladewig D, editor. Drogen und Alkohol: ISPA Press Lausanne; 1988a. p. 119–34.Google Scholar
  79. Lesch OM, Bonte W, Walter H, Musalek M, Sprung R. Verlaufsorientierte Alkoholismus diagnostik. In: Schwoon DR, Krausz M, editors. Suchtkranke – Die ungeliebten Kinder der Psychiatrie: Ferdinand Enke Verlag; 1990b. p. 81–91.Google Scholar
  80. Lesch OM, Dietzel M, Musalek M, Walter H, Zeiler K. The course of alcoholism. Long – term prognosis in different types. Forensic Sci Int. 1988b;36(1–2):121–38.PubMedCrossRefGoogle Scholar
  81. Lesch OM, Dietzel M, Musalek M, Walter H, Zeiler K. Therapiekonzepte und Therapieziele im Lichte langfristiger Katamnesen. In: Kunze M, Schoberberger R, editors. Psychosomatik 2000. Neue Aspekte. Wien: Dr. Peter Müller Verlag; 1990a. p. 161–78.Google Scholar
  82. Lesch OM, Dietzel-Rogan M, Musalek M, Rajna P, Rustem-Begovich A, Schjerve M, Walter H. Soziale Integration paraphrener Langzeitpatienten bei niedrigdosierter Depotneuroleptikamedikation. Psychiatr Prax. 1985a;12:63–8.PubMedGoogle Scholar
  83. Lesch OM, Dvorak A, Hertling I, Klingler A, Kunze M, Ramskogler K, Saletu-Zylharz G, Schoberberger R, Walter H. The Austrian multicentre study on smoking: subgroups of nicotine dependence and their craving. Neuropsychobiology. 2004;50:78–88.PubMedCrossRefPubMedCentralGoogle Scholar
  84. Lesch OM, Grünberger J, Rajna P. Das Model “Burgenland”. In: Mader R, editor. Alkohol- und Drogenabhängigkeit, Neue Ergebnisse aus Theorie und Praxis; 1983. p. 155–89.Google Scholar
  85. Lesch OM, Grünberger J, Rajna P. Outpatient treatment of alcohol addicts – the Burgenland model. Med Law,. Springer Verlag. 1985b;4:71–6.PubMedGoogle Scholar
  86. Lesch OM, Hertling I, Ramskogler K, Riegler A, Dvorak A, Walter H. Gender differences in smoking. Women’s mental health – a central European collaborative research discourse, Halbreich U, Gaszner P, Saletu B, editors. 2006; p. 32–37.Google Scholar
  87. Lesch OM, Kefer J, Lentner S, Mader R, Marx B, Musalek M, Nimmerrichter A, Preinsberger H, Puchinger H, Rustembegovic A, Walter H, Zach E. Diagnosis of ChronicAlcoholism – classificatory problems. Psychopathology. 1990c;23(2):88–96.PubMedCrossRefPubMedCentralGoogle Scholar
  88. Lesch OM, Lang A, Rajna R. (1980) Bericht über den Einfluss eine Behandlungsstruktur auf das Suchtverhalten der burgenländischen Patienten, die in der Zeit zwischen dem 1. Jänner 1973 und dem 31. Dezember 1975 im Anton-Proksch-Institut aufgenommen waren. Wiener Zeitschrift für Suchtforschung, Jahrgang 3:7–14.Google Scholar
  89. Lesch OM, Lentner-Jedlicka S, Walter H. Umgang mit Alkoholkranken und anderen Süchtigen. Wien Klin Wochenschr. 1984;96(21):790–6.PubMedGoogle Scholar
  90. Lesch OM, Riegler A, Gutierrez K, Hertling I, Ramskogler K, Semler B, Zoghlami A, Benda N, Walter H. The European Acamprosate trials: conclusions for research and therapy. J Biomed Sci. 2001;8(1):89–95.PubMedCrossRefGoogle Scholar
  91. Lesch OM und Walter H. Chronischer Alkoholismus und Mortalität. Gemeindenahe Psychiatrie, Heft 1 und 2, Nr. 17/18:46–54; 1984.Google Scholar
  92. Lesch OM, Walter H, Antal J, Heggli DE, Kovacz A, Leitner A, Neumeister A, Stumpf I, Sundrehagen E, Kasper S. Carbohydrate deficient transferrin as a marker for alcohol intake: a study with healthy subjects. Alcohol Alcohol. 1996a;31(3):265–71.PubMedCrossRefGoogle Scholar
  93. Lesch OM, Walter H, Antal J, Kanitz RD, Kovacs A, Leitner A, Marx B, Neumeister A, Saletu M, Semler B, Stumpf I, Mader R. Alcohol dependence. Is carbohydrate deficient transferrin a marker for alcohol intake? Alcohol Alcohol. 1996b;31(3):257–64.PubMedCrossRefGoogle Scholar
  94. Lesch OM, Walter H, Freitag H, Heggli DE, Leitner A, Mader R, Neumeister A, Passeg V, Pusch H, Semler B, Sundrehagen E, Kasper S. Carbohydrate deficient transferrin as a screening marker for drinking in a general hospital population. Alcohol Alcohol. 1996c;31(3):249–56.PubMedCrossRefGoogle Scholar
  95. Lesch OM, Walter H, Mader R, Musalek M, Zeiler K. Chronic alcoholism in relation to attempted or effected suicide – a long-term-study. Psychiatr Psychobiol. 1988c;3:181–8.Google Scholar
  96. Lesch OM, Walter H, Rommelspacher H. Alcohol abuse and alcohol dependence. In: MPI W, van Kammen DP, editors. Rommelspacher H, Schuckit M. (Guest Eds.). “Drugs of Abuse” Baillière’s Clinical Psychiatry 2/3, Baillière’s Clinical Psychiatry, Baillière Tindall, London-Philadelphia-Sydney-Tokio-Toronto ; 1996d. p. 421–44.Google Scholar
  97. Malka R, Fouquet P, Vachorfrance G. Alcoologie. Paris: Masson; 1983.Google Scholar
  98. McLellan AT, Luborsky I, O’Brien CP, Woody GE. An improved evaluation instrument for substance abuse patients: the addiction severity index. J Nerv Ment Dis. 1980;168:26–33.PubMedCrossRefGoogle Scholar
  99. Mendelsohn CP. Three decades of high-dose nicotine gum dependence treated with nicotine patches. Nicotine Tob Res. 2016;18(5):1220–1. ReviewPubMedCrossRefGoogle Scholar
  100. Michalak A, Biała G. Alcohol dependence – neurobiology and treatment. Acta Pol Pharm. 2016;73(1):3–12.PubMedGoogle Scholar
  101. Morey LC, Blashfield RK. Empirical classifications of alcoholics. J Stud Alcohol. 1981;42:925–37.PubMedCrossRefGoogle Scholar
  102. Mueller SE, Degen B, Petitjean S, Wiesbeck GA, Walter M. Gender differences in interpersonal problems of alcohol – dependent patients and healthy controls. Int J Environ Res Public Health. 2009;6:3010–22.PubMedPubMedCentralCrossRefGoogle Scholar
  103. Nakamura-Palacios EM, de Almeida Benevides MC, da Penha Z-GM, de Oliveira RW, de Vasconcellos VF, de Castro LN, da Silva MC, Ramos PA, Fregni F. Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology. Int J Neuropsychopharmacol. 2012;15(5):601–16.PubMedCrossRefGoogle Scholar
  104. National Institute for Clinical Excellence (2004) Guidance on the Use of Nicotine Replacement Therapy (NRT) and Bupropion for Smoking Cessation. London, England: National Institute for Clinical Excellence, Reference No. N0082.Google Scholar
  105. Nicolas JM, Fernandez-Sola J, Fatjo F, Casamitjana R, Bataller R, Sacanella E, Tobias E, Badia E, Estruch R. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res. 2001;25(1):83–8.PubMedCrossRefGoogle Scholar
  106. Patton D, Barnes GE, Murray RP. A personality typology of smokers. Addict Behav. 1997;22:269–73.PubMedCrossRefGoogle Scholar
  107. Platz W. Forensische Psychiatrie. In: Brüssow R, Gatzweiler N, Krekeler W, Mehle V, editors. Strafverteidigung in der Praxis. 4th ed: Deutscher Anwalt Verlag; 2007.Google Scholar
  108. Pombo S, da Costa NF, Figueira ML, Ismail F, Lesch OM. Multidimensional alcoholism typologies: could they guide clinical practice? Results from a 3-month prospective study. Int J Psychiatry Clin Pract. 2015;19(2):137–47.PubMedCrossRefGoogle Scholar
  109. Pombo S, Lesch OM. The alcoholic phenotypes among different multidimensional typologies: similarities and their classification procedures. Alcohol Alcohol. 2009;44(1):46–54.PubMedCrossRefGoogle Scholar
  110. Pombo S, Reizinho R, Ismail F, Barbosa A, Figueira LM, Cardoso JMN, Lesch OM. NETER1 alcoholic 5 subtypes: validity with Lesch four evolutionary subtypes. Int J Psychiatry Clin Pract. 2008;12(1):55–64.PubMedCrossRefGoogle Scholar
  111. Pomerleau CS, Marks JL, Pomerleau OF. Who gets what symptom? Effects of psychiatric co-factors and nicotine dependence on patterns of smoking withdrawal symptomatology. Nicotine Tob Res. 2000;2:275–80.PubMedCrossRefGoogle Scholar
  112. Procopio DO, Saba LM, Walter H, Lesch O, Skala K, Schlaff G, Vanderlinden L, Clapp P, Hoffman PL, Tabakoff B. Genetic markers of comorbid depression and alcoholism in women. Alcohol Clin Exp Res. 2013;37(6):896–904.PubMedCrossRefGoogle Scholar
  113. Purshouse RC, Brennan A, Moyo D, Bicholls J, Norman P. Typology and dynamics of Haevier drinking styles in Great Britain: 1978–2010. Alcohol Alcohol. 2017;52(3):372–81.PubMedPubMedCentralGoogle Scholar
  114. Reulbach U, Biermann T, Bleich S, Hillemacher T, Kornhuber J, Sperling W. Alcoholism and homicide with respect to the classification systems of Lesch and Cloninger. Alcohol Alcohol. 2007;42(2):103–7.PubMedCrossRefGoogle Scholar
  115. Roache JD, Wang Y, Ait-Daoud N, Johnson BA. Prediction of serotonergic treatment efficacy using age of onset and type a/B typologies of alcoholism. Alcohol Clin Exp Res. 2008;32(8):1502–12.PubMedPubMedCentralCrossRefGoogle Scholar
  116. Rolland B, Paille F, Gillet C, Rigaud A, Moirand R, Dano C, Dematteis M, Mann K, Aubin HJ. Pharmacotherapy for alcohol dependence: the 2015 recommendations of the French alcohol society, issued in partnership with the European Federation of Addiction Societies. CNS Neurosci Ther. 2016;22(1):25–37.PubMedCrossRefGoogle Scholar
  117. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatr. 1987;44:505–13.PubMedCrossRefGoogle Scholar
  118. Saffroy R, Pham P, Chiappini F, Gross-Goupil M, Castera L, Azoulay D, Barrier A, Samuel D, Debuire B, Lemoine A. The MTHFR 677 C>T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis. 2004;25(8):1443–8.PubMedCrossRefGoogle Scholar
  119. Salem BA, Vyssoki B, Lesch OM, Erfurth A. Lesch typology and temperament in opioid dependence: a cross-sectional study. J Affect Disord. 2014;165:203–7.PubMedCrossRefGoogle Scholar
  120. Samochowiec A. The influence of parents personality measured by temperamental and character inventory (TCI) on course of alcoholism characterized by Cloninger's and Lesch's typologies. Ann Acad Med Stetin. 2010;56(2):33–9.PubMedGoogle Scholar
  121. Samochowiec A, Chęć M, Kopaczewska E, Samochowiec J, Lesch O, Grochans E, Jasiewicz A, Bienkowski P, Łukasz K, Grzywacz A. Monoamine oxidase a promoter variable number of tandem repeats (MAOA-uVNTR) in alcoholics according to Lesch typology. Int J Environ Res Public Health. 2015;12(3):3317–26.PubMedPubMedCentralCrossRefGoogle Scholar
  122. Samochowiec A, Chęć M, Kopaczewska E, Samochowiec J, Lesch O, Jasiewicz A, Grochans E, Jabłoński M, Bieńkowski P, Kołodziej Ł, Grzywacz A. Case control study of ANKK1 Taq 1A polymorphism in patients with alcohol dependence classified according to Lesch's typology. Postepy Hig Med Dosw (Online). 2016;70:420–4.CrossRefGoogle Scholar
  123. Samochowiec A, Horodnicki JM, Samochowiec J. The influence of parents personality and DRD4 and 5HTT genes polymorphisms on predisposition to alcohol dependence in their sons. Psychiatr Pol. 2011;45(3):337–47.PubMedGoogle Scholar
  124. Samochowiec J, Kucharska-Mazur J, Grzywacz A, Pelka-Wysiecka J, Mak M, Samochowiec A, Bienkowski P. Genetics of Lesch’s typology of alcoholism. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):423–7.PubMedCrossRefGoogle Scholar
  125. Schoberberger R, Kunze M. Nikotinabhängigkeit – Diagnostik und Therapie: Springer Verlag; 1999.Google Scholar
  126. Scholz H. Syndrombezogene Alkoholismustherapie. Ein verlaufsorientierter Stufenplan für die Praxis. Verlag für Psychologie, Göttingen, Bern, Toronto, Seattle: Hogrefe; 1996.Google Scholar
  127. Schuckit MA. The clinical implications of primary diatgnostic groups among alcoholics. Arch Gen Psychiatry. 1985;42:1043–9.PubMedCrossRefGoogle Scholar
  128. Schuckit MA, Tipp J, Smith TL, Shapiro E, Hesselbrock V, Bucholz K, Reich T, Nurnberger JI Jr. An evaluation of type A and type B alcoholics. Addiction. 1995;90:1189–204.PubMedCrossRefGoogle Scholar
  129. Shiffman S, Gnys M, Richards TJ, Paty JA, Hickcox M, Kassel JD. Temptations to smoke after quitting: a comparison of lapsers and maintainers. Health Psychol. 1996;15:455–61.PubMedCrossRefPubMedCentralGoogle Scholar
  130. Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. 2001;36(1):2–10.PubMedCrossRefGoogle Scholar
  131. Skinner HA. Statistical approaches to the classification of alcohol and drug addiction. Br J Addict. 1982;77:259–73.PubMedCrossRefGoogle Scholar
  132. Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann K. The cannabinoid receptor 1 antagonist SR 141716 (Rimonabant) for treatment of alcohol dependence – results from a placebo-controlled double-blind trial. J Clin Psychopharmacol. 2008;28(3):317–24.PubMedCrossRefPubMedCentralGoogle Scholar
  133. Soyka M, Müller CA. Pharmacotherapy of alcoholism – an update on approved and off-label medications. Expert Opin Pharmacother. 2017;18(12):1187–99.PubMedCrossRefPubMedCentralGoogle Scholar
  134. Sperling W, Frank H, Lesch OM, Mader R, Ramskogler K, Barocka A. Untergruppen Alkoholabhängiger und ihre primäre Vulnerabilität- Eine Untersuchung zweier Typologien (Cloninger, Lesch). Wiener Zeitschrift für Suchtforschung. 1999;22(4):21–6.Google Scholar
  135. Sperling W, Frank H, Martus P, Mader R, Barocka A, Walter H, Lesch M. The concept of abnormal hemispheric organization in addiction research. Alcohol Alcohol. 2000;35(4):394–9.PubMedCrossRefGoogle Scholar
  136. Spielhofer H, Lesch OM. Probleme bei der Rehabilitation psychisch Kranker im ländlichen Raum. Bericht über ein Wohn- und Arbeitsheim im Burgenland (Großpetersdorf). In: Finzen A, Koester H, Rose HK, editors. Psychiatrische Praxis 7/4. Stuttgart – New York: Georg Thieme Verlag; 1980. p. 247–54.Google Scholar
  137. Stanger O, Weger M, Renner W, Konetschny R. Vascular dysfunction in hyperhomocyst(e) inemia. Implications for atherothrombotic disease. Clin Chem Lab Med. 2001;39(8):725–33.PubMedCrossRefGoogle Scholar
  138. Tarter REH, McBride RN, Bounparte N, Schneider DU. Differentiation of alcoholics. Arch Gen Psychiatr. 1977;34:761–8.PubMedCrossRefGoogle Scholar
  139. UNDOC and WHO Commission on Narcotic Drugs (2016) International standards for the treatment of drug use disorders.Google Scholar
  140. Van de Bree A, Verschuren WMM, Kromhout D, Kluitmans LAJ, Blom HJ. Homocysteine determinants and to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev. 2002;54:599–618.PubMedCrossRefPubMedCentralGoogle Scholar
  141. Van den Bree MBM, Svilkis DS, Pickens RW. Genetic influences in antisocial personality and drug use disorders. Drug Alcohol Depend. 1998;49:177–81.PubMedCrossRefGoogle Scholar
  142. Van den Brink W, Addolorato G, Aubin HJ, Benjamina A, Caputo F, Dematteis M, Gual A, Lesch OM, Mann K, Maremanni I, Nutt D, Paille F, Perney P, Rehm J, Reynaud M, Simon N, Söderpalm B, Sommer WH, Walter H, Spanagel R. Efficacy and safety of sodium oxybate in alcohol dependent patients with a very high drinking risk level. Addict Biol. 2018;23(4):969–86.PubMedCrossRefGoogle Scholar
  143. Van den Brink W, Montgomery SA, Van Ree JM, van Zwieten-Boot BJ. ECNP Consensus Meeting March 2003 Guidelines for the investigation of efficacy in substance use disorders. Eur Neuropsychopharmacol. 2006;16:224–30.PubMedCrossRefGoogle Scholar
  144. Verschuren WMM, Kromhout D, Kluitmans LAJ, Blom HJ. Homocysteine determinants and to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev. 2002;54:599–618.PubMedCrossRefGoogle Scholar
  145. Vyssoki B, Blüml V, Gleiss A, Friedrich F, Kogoj D, Walter H, Zeiler J, Höfer P, Lesch OM, Erfurth A. The impact of temperament in the course of alcohol dependence. J Affect Disord. 2011;135(1–3):177–83.PubMedCrossRefGoogle Scholar
  146. Vyssoki B, Steindl-Munda P, Ferenci P, Walter H, Höfer P, Blüml V, Friedrich F, Kogoj D, Lesch OM. Comparison of alcohol-dependent patients at a gastroenterological and a psychiatric ward according to the Lesch alcoholism typology: implications for treatment. Alcohol Alcohol. 2010;45(6):534–40.PubMedCrossRefGoogle Scholar
  147. Walter H. Alkohol. In Revenstorf D. und Peter B.; Hypnose in Psychotherapie, Psychosomatik und Medizin. Manual für die Praxis. 2015;365–72. Springer Verlag /2. Aufl. Heidelberg.Google Scholar
  148. Walter H, Hertling I, Benda N, König B, Ramskogler K, Riegler A, Semler B, Zoghlami A, Lesch OM. Sensitivity and specificity of carbohydrate-deficient transferrin in drinking experiments and different patients. Alcohol. 2001a;25(3):189–94.PubMedCrossRefPubMedCentralGoogle Scholar
  149. Walter H, Ramskogler K, Semler B, Lesch OM, Platz W. Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. J Biomed Sci. 2001b;8:83–8.PubMedCrossRefGoogle Scholar
  150. Walter H, Ramskogler-Skala K, Dvorak A, Gutierrez-Lobos K, Hartl D, Hertling I, Munda P, Thau K, Lesch OM, De Witte P. Glutamic acid in withdrawal and weaning in patients classified according to Cloninger's and Lesch's typologies. Alcohol Alcohol. 2006;41(5):505–11.PubMedCrossRefGoogle Scholar
  151. Weinland C, Braun B, Mühle C, Kornhuber J, Lenz B. Cloninger type 2 score and Lesch typology predict hospital readmission of female and male alcohol-dependent inpatients during a 24-month follow-up. Alcohol Clin Exp Res. 2017;41(10):1760–7.PubMedCrossRefGoogle Scholar
  152. Wiesbeck G, Weijers HG, Lesch OM, Glaser T, Toennes PJ, Boening J. Flupenthixol Decanoate and relapse prevention in alcoholics: results from a placebo-controlled study. Alcohol Alcohol. 2001;36(4):329–34.PubMedCrossRefGoogle Scholar
  153. Wirnsberger K, Walter H, Lesch OM, Hartl D. Different degrees of liver damage between subgroups of alcohol-addicted persons. Alcohol Alcohol. 2007;42(1):i56.Google Scholar
  154. Wurst FM, Bechtel G, Forster S, Wolfersdorf M, Huber P, Scholer A, Pridzun L, Alt A, Seidl S, Dierkes J, Dammann G. Leptin levels of alcohol abstainers and detoxification patients are not different. Alcohol Alcohol. 2003;38(4):364–8.PubMedCrossRefGoogle Scholar
  155. Zago-Gomes Mda P, Nakamura-Palacios EM. Cognitive components of frontal lobe function in alcoholics classified according to Lesch's typology. Alcohol Alcohol. 2009;44(5):449–57.PubMedCrossRefGoogle Scholar
  156. Zimmermann P, Wittchen HU, Höfler M, Pfister H, Kessler RC, Lieb R. Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med. 2003;33:1211–22.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Clinical Division of Social PsychiatryMedical University Vienna, Department of Psychiatry and PsychotherapyViennaAustria
  2. 2.Caritas der Erzdiözese WienViennaAustria
  3. 3.Department of PsychiatryUniversity of Connecticut Health CenterFarmingtonUSA
  4. 4.Neuroscience DepartmentHospital de Santa MariaLisboaPortugal

Personalised recommendations